Research Article| Volume 18, SUPPLEMENT 2, 37-42, 1996

Viral safety of blood derivatives: an overview

      This paper is only available as a PDF. To read, Please Download here.


      The causes of past accidental viral transmissions associated with blood derivatives are reviewed briefly, as are the safety procedures instituted in Europe on the basis of viral validation studies. A comprehensive five-class classification system for delineating viral risk according to source material and comparative viral safety is presented. Newly emerging viruses are briefly discussed in view of the viral safety of blood products.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Choo QL
        • Kuo G
        • Weiner AJ
        • et al.
        Isolation of a cDNA derived from a blood-borne non-A, non-B hepatitis genome.
        Science. 1989; 244: 359-362
        • Horaud F
        • Brown F
        Virological aspects of the safety of biological products.
        Dev Biol Stand. 1991; : 75
        • Brown F
        Virological safety aspects of plasma derivatives.
        Dev Biol Stand. 1993; : 81
        • Horaud F
        Viral safety of biologicals.
        Dev Biol Stand. 1991; 75: 3-7
        • Horaud F
        Biologicals: An attempt at classification and its implication for the viral safety of products.
        Dev Biol Stand. 1993; 81: 17-24
        • Morgenthaler
        Virus inactivation in plasma products.
        Curr Stud Hematol Blood Trans-fus. 1989; : 56
        • EEC Regulatory Document
        Validation of virus removal and inactivation procedures.
        Biologicals. 1991; 19: 247-251
        • EEC Regulatory Document
        Guidelines for medicinal products derived from human blood and plasma.
        Biologicals. 1991; 20: 159-164
        • Findlay MG
        • MacCallum OF
        • Murgatroyd F
        Observation bearing on the etiology of infective hepatitis (called epidemic catarrhal jaundice).
        Trans R Soc Trop Med Hyg. 1939; 32: 575-580
      1. Transmissible spongiform encephalopathies: Impact on animal and human health.
        Dev Biol Stand. 1992;
      2. Morse SS Emerging Viruses. Oxford University Press, Oxford, England1993
        • Peters CJ
        • Sanchez A
        • Feldman H
        • et al.
        Filoviruses as emerging pathogen.
        Semin Virol. 1994; 5: 147-154
        • Murray K
        • Selleck P
        • Hooper P
        • et al.
        A morbillivirus that caused fatal disease in horses and humans.
        Science. 1995; 268: 94-97
        • Houghton M
        • Richman K
        • Han J
        • et al.
        Hepatitis C virus (HCV): A relative of the pestiviruses and flaviviruses.
        in: Hollinger BF Lemon SM Margolis HS Viral Hepatitis and Liver Disease. Williams & Wilkins, Baltimore, MD1990: 321-323